文献速递重症综合管理与镇静镇痛

大型ICU代理决策者队列中长期决策后悔的患病率及相关危险因素

Prevalence of long-term decision regret and associated risk factors in a large cohort of ICU surrogate decision makers.
PubMed 文献 · Crit Care · 2023-02-16
一句话结论约五分之一ICU代理决策者对生命支持决策存在中度至强烈后悔,患者不良结局与死亡前限制生命支持决策与更多后悔相关。

该研究为PARTNER 2试验的二次分析,纳入848名危重成人代理决策者,6个月随访时用决策后悔量表(DRS,0-100分,分数越高后悔越强)评估。748名有完整DRS数据者中,DRS中位数15(IQR 0,25),54%轻度后悔(DRS 5-25),19%中度至强烈后悔(DRS 30-100),27%无后悔(DRS 0)。模型1中6个月患者不良结局(死亡或严重功能依赖)与更多后悔相关(β 10.1;95%CI 3.2,17.0);模型2中姑息治疗会诊(β 3.0;95%CI 0.1,5.9)、死亡前限制生命支持(β 6.3;95%CI 3.1,9.4)和代理决策者黑人种族(β 6.3;95%CI 0.3,12.3)与更多后悔相关。亚组分析中后悔的其他调节因素包括代理决策者年龄和教育水平、代理决策者与患者关系、院内死亡(相较于出院后时期)及入ICU时复苏状态。

要点

  • 748名有完整DRS数据的代理决策者中,19%报告中度至强烈后悔(DRS 30-100),54%轻度后悔(DRS 5-25),27%无后悔(DRS 0)。
  • 模型1中,6个月患者不良结局(死亡或严重功能依赖)与更多后悔相关(β 10.1;95%CI 3.2,17.0)。
  • 模型2中,姑息治疗会诊与更多后悔相关(β 3.0;95%CI 0.1,5.9)。
  • 模型2中,死亡前限制生命支持与更多后悔相关(β 6.3;95%CI 3.1,9.4)。
  • 模型2中,代理决策者黑人种族与更多后悔相关(β 6.3;95%CI 0.3,12.3)。

适用人群与场景

  • 成年ICU患者的代理决策者,数据来自PARTNER 2试验(该试验测试针对危重成人代理决策者的家庭支持干预)。

诊断标准与关键阈值

  • 决策后悔量表(DRS)评分0-100分,分数越高表示后悔越强;轻度后悔为DRS 5-25,中度至强烈后悔为DRS 30-100,无后悔为DRS 0。

研究设计与关键结果

  • 研究类型:PARTNER 2试验的二次分析;848名代理决策者中748名有完整DRS数据。
  • 6个月随访时DRS中位数15(IQR 0,25);54%轻度后悔(DRS 5-25),19%中度至强烈后悔(DRS 30-100),27%无后悔(DRS 0)。
  • 模型1(包含患者结局):6个月患者不良结局(死亡或严重功能依赖)与更多后悔相关(β 10.1;95%CI 3.2,17.0)。
  • 模型2(关注ICU决策时已知协变量):姑息治疗会诊(β 3.0;95%CI 0.1,5.9)、死亡前限制生命支持(β 6.3;95%CI 3.1,9.4)和代理决策者黑人种族(β 6.3;95%CI 0.3,12.3)与更多后悔相关。
  • 亚组分析中后悔的其他调节因素包括代理决策者年龄和教育水平、代理决策者与患者关系、院内死亡(相较于出院后时期)及入ICU时复苏状态。

证据类型、等级与局限

  • 证据类型:PARTNER 2试验的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,需要未来研究来理解后悔与决策质量的关系以及如何减轻持久后悔。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Whether surrogate decision makers regret decisions about the use of life support for incapacitated, critically ill patients remain uncertain. We sought to determine the prevalence of decision regret among surrogates of adult ICU patients and identify factors that influence regret.

METHODS: We conducted a secondary analysis of data from the PARTNER 2 trial, which tested a family support intervention for surrogates of critically ill adults. At 6-month follow-up, surrogates rated their regret about life support decisions using the Decision Regret Scale (DRS), scored from 0 to 100, with higher scores indicating more regret. We used multiple linear regression to identify covariates associated with decision regret based on a psychological construct of regret. We constructed two models using the full cohort; model 1 included patient outcomes; model 2 focused on covariates known at the time of ICU decision-making. Subgroup analyses were also conducted based on patient survival status at hospital discharge and 6-month follow-up.

RESULTS: 748 of 848 surrogates had complete DRS data. The median (IQR) DRS score was 15 (0, 25). Overall, 54% reported mild regret (DRS 5-25), 19% moderate-strong regret (DRS 30-100), and 27% no regret (DRS 0). Poor patient outcome at 6 months (death or severe functional dependence) was associated with more regret in model 1 (β 10.1; 95% C.I. 3.2, 17.0). In model 2, palliative care consultation (3.0; 0.1, 5.9), limitations in life support (LS) prior to death (6.3; 3.1, 9.4) and surrogate black race (6.3; 0.3, 12.3) were associated with more regret. Other modulators of regret in subgroup analyses included surrogate age and education level, surrogate-patient relationship, death in hospital (compared to the post-discharge period), and code status at time of ICU admission.

CONCLUSIONS: One in five ICU surrogate decision makers experience moderate to strong regret about life support decisions in ICU. Poor patient outcomes are linked to more regret. Decisions to limit life support prior to patient death may also increase regret. Future studies are needed to understand how regret relates to decision quality and how to lessen lasting regret.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Andersen SK, Butler RA, Chang CH, et al. Prevalence of long-term decision regret and associated risk factors in a large cohort of ICU surrogate decision makers. Crit Care. 2023. PMID: 36797793. doi:10.1186/s13054-023-04332-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。